Khosla Ventures Acquisition Co
Change company Symbol lookup
Select an option...
KVSA Khosla Ventures Acquisition Co
FPI Farmland Partners Inc
HNST Honest Company Inc
ONTF ON24 Inc
ATAI ATAI Life Sciences NV
FTS Fortis Inc
VLO Valero Energy Corp
BBLN+ Babylon Holdings Equity Warrants 21st Oct 2026 *W EXP 10/21/2026
NEGG Newegg Commerce Inc
LTRY Lottery.com Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Company profile

Khosla Ventures Acquisition Co. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search on market opportunity with differentiated, proprietary technology. The Company has not commenced any operations and has not generated revenues.

Closing Price
$9.81
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.82
Day's Low
9.79
Volume
(Heavy Day)
Volume:
172,786

10-day average volume:
19,311
172,786

WSJ: Pfizer considering buying Global Blood Therapeutics for roughly $5 billion

11:58 am ET August 5, 2022 (MarketWatch)
Print

Shares of Global Blood Therapeutics Inc. (GBT) jumped 9.5% in trading on Friday after The Wall Street Journal reported that Pfizer Inc. (PFE) is considering buying the company for about $5 billion. There were media reports earlier this week that Global Blood Therapeutics, which markets a sickle-cell treatment, is attracting takeover interest. The company's stock is up 79.6% this year, while the broader S&P 500 is down 12.8%.

-Jaimy Lee

	

(END) Dow Jones Newswires

August 05, 2022 11:58 ET (15:58 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.